Several new devices that monitor haemodynamics have been introduced with the aim of reducing the need for haemodynamic invasive monitoring. Bioreactance is potentially attractive since it only requires four electrodes stickers placed on the thorax. 1 This technique is based upon the measurement of frequency modulation and signal phase shift of an electrical current crossing the thorax, the variations of which are related to changes in the volume of the thoracic aorta. 2 This allows estimation of the volume of blood ejected in the thoracic aorta with each heart beat. The validation of this technique is still ongoing and initial results are conflicting. While some studies found good agreement between bioreactance and a reference technique, 3 -5 others found less promising results. 6 -9 Our aim was to compare the values of cardiac output measured by a bioreactance device (NICOM w , Cheetah Medical, Tel Aviv, Israel) with the values provided by transpulmonary thermodilution. Particularly, we evaluated the capacity of the NICOM w to track the changes in cardiac index (CI) during a passive leg raising (PLR) test and to predict fluid responsiveness.
Methods

Population
This prospective study took place in the medical intensive care unit (ICU) of a university hospital. It was approved by the institutional review board of our institution (Comité pour la Protection des Personnes Ile de France VII). All patients (or next of kin) gave informed consent. The inclusion criteria were (i) the presence of an acute haemodynamic failure, as defined by a systolic arterial pressure ≤90 mm Hg or a decrease ≥40 mm Hg compared with the usual systolic arterial pressure, skin mottling, blood lactate ≥2 mmol litre 21 , urine output ≤0. 
Bioreactance and transpulmonary thermodilution measurements
Derived from the original bioimpedance technique, the NICOM w system sends a high-frequency current with known low amplitude through the thorax using four electrodes and measures the frequency-modulation and phase-modulation resulting from the changes in the thoracic blood volume through four other adjacent electrodes. After placing the electrodes and recording patients' characteristics, the NICOM w automatically calibrates and then provides a continuous CI value.
The PiCCO 2 TM system requires a central venous catheter in the superior vena cava territory and a femoral thermistortipped arterial catheter (PV2024 Pulsion Medical Systems). The latter is connected to a pressure sensor (PV8115 Pulsion Medical Systems). The PiCCO 2 device measures CI in two different ways. First, transpulmonary thermodilution principle provides an intermittent measure of CI. After injection of a 15 ml cold bolus through the central venous line, cardiac output is computed from the blood temperature curve recorded by the arterial catheter. With this technique, if CI is calculated as the average of three consecutive thermodilution measurements, its least significant is 12%. 10 Secondly, pulse contour analysis provides a continuous and real-time estimation of CI. It is based upon the principle that the area under the systolic part of the arterial signal is physiologically proportional to stroke volume. The PiCCO 2 TM calibrates the initial value of CI by transpulmonary thermodilution. After calibration, pulse contour analysis allows the continuous display of CI values.
Study design
At baseline, the CI values provided by the NICOM w (CI Nicom ) and PICCO 2 TM (transpulmonary thermodilution, Cl td ) devices were recorded simultaneously. A PLR test was then performed by moving the patient's bed from a semi-recumbent position to a position in which the trunk was horizontal and lower limbs raised at 458. At the time when PLR induced its maximal haemodynamic effects (i.e. within 1 min), CI Nicom and CI provided by pulse contour analysis were recorded. Then, the patient was placed back into the semi-recumbent position and CI values were allowed to return to baseline. The PiCCO 2 TM device was recalibrated and the CI Nicom and CI td were recorded.
During the next 10 min, 500 ml saline was infused to cause intravascular volume expansion. After volume expansion, CI Nicom and CI td were again recorded simultaneously. Values of CI td (recorded at baseline, after return to the semirecumbent position, and after volume expansion) vs CI Nicom were compared using the Bland -Altman analysis. CI was used for analysis considering that the reliability of a device for measuring absolute variables of CI is similar than for cardiac output. The percentage error was calculated as 2SD divided by the mean of CI td .
Data analysis
The percentage changes in CI td and CI Nicom induced by volume expansion were compared by linear regression analysis (for per cent change). Percentage changes were taken into account rather than the absolute changes because they take into consideration that the impact of an error in cardiac output measurement is not the same depending upon the absolute value of cardiac output measured by the reference technique. For assessing the ability of CI Nicom to follow trends, we constructed a four-quadrant plot, as described by Critchley and colleagues. 11 We considered as 'volume-responders' patients responding to volume expansion by an increase of at least 15% of CI td . The other patients were considered as 'non-volume-responders'. For testing the ability of the changes in CI Nicom and CI provided by pulse contour analysis induced by the PLR test to predict fluid responsiveness, we constructed receiver operating characteristics (ROC) curves. Sensitivity and specificity are expressed as median (95% confidence interval). The cut-off values of changes in CI Nicom and CI provided by pulse contour analysis for predicting volume responsiveness by the PLR test were considered as those providing the lowest Youden index. A P-value of ,0.05 was considered statistically significant. The statistical analysis was performed with the MedCalc 8.1.0.0 software (Mariakerke, Belgium).
Results
Patients
Forty-eight patients were included in the study (Table 1) . No patient was excluded. Sepsis was the aetiology of shock in 83% of the patients and a majority presented an acute respiratory distress syndrome. Eleven patients presented cardiac arrhythmias, spontaneous breathing activity, or both.
Comparison of absolute values of CI td and CI Nicom
When considering all pairs of CI td and CI Nicom measurements (at baseline before PLR, before volume expansion, and after volume expansion, n¼144), the bias between CI td and CI Nicom was 20. Comparison of the changes in CI td and CI Nicom
As described in Table 2 , pulse contour analysis-derived CI and CI Nicom significantly increased during PLR and after volume expansion in volume-responders. Pulse contour analysisderived CI did not significantly change either during PLR or after volume expansion in non-volume-responders. However, CI Nicom did significantly increase during PLR in non-volumeresponders.
There was no significant correlation between the changes in pulse contour analysis-derived CI td and CI Nicom induced by volume expansion (P¼0.24, Fig. 2 ). The concordance rate between changes in CI td and CI Nicom induced by volume expansion was 43% (Fig. 2) , meaning that in 43% of instances, CI td and CI Nicom changed in the same direction. When excluding changes ,15%, the concordance rate was 52% (Fig. 2) .
Ability of the PiCCO and Nicom devices to assess the effects of the PLR test
The area under the ROC curve constructed to assess the ability of PLR-induced changes in pulse contour analysis-derived CI was 0.87 (0.06) (P,0.001) (Fig. 3 ).
An increase in pulse contour analysis-derived CI by .9% during the PLR test allowed prediction of fluid responsiveness with a sensitivity of 84% (95% confidence interval 60-97%), a specificity of 97% (82 -100%), a positive predictive value of 94% (70-100%), and a negative predictive value of 90% (74 -98%).
The area under the ROC curve constructed for testing the ability of the PLR-induced changes in CI Nicom did not differ significantly from 0.5 (P¼0.77) (Fig. 3 ).
Discussion
Our study showed that the NICOM w device is unable to provide a reliable estimate of CI in critically ill patients. The ability of the NICOM w device to detect changes in CI was also poor. As a consequence, the NICOM w could not assess the effects of the PLR test to test fluid responsiveness.
During the last years, major efforts have been made in order to develop devices measuring and monitoring cardiac output. In particular, the aim was to obtain less-invasive or noninvasive measurements. In this context, the NICOM w device is completely non-invasive since it only requires four double electrode stickers placed on the thorax. The measure of cardiac output by the NICOM w is based upon bioreactance technology, which is an evolution of the bioimpedance principle. With bioimpedance, a constant high-frequency current with known amplitude is applied to the thorax by cutaneous electrodes. The bioimpedance devices measure the variations in tension resulting from the changes in thoracic impedance through four adjacent electrodes. At each systole, the thoracic impedance decreases in proportion of the increase in the intrathoracic iron amount and thus in proportion to the augmentation of thoracic blood volume. The variations in thoracic impedance are in fact mainly due to the variations of the aortic volume (i.e. variations of stroke volume). 12 With bioreactance, it is not the changes in the amplitude of the signal that are measured but the changes in frequency. This allows to substantially improve the signal-to-noise ratio. 3 The ability of the device to measure cardiac output might be limited by variations in thoracic impedance due to other causes (variations in the thoracic blood volume due to respiration, arrhythmias, etc.).
Comparing bioreactance with transpulmonary thermodilution, we conclude that NICOM w was not reliable to assess the cardiac output or to predict the effects on the cardiac output of a PLR or fluid responsiveness. In the Bland -Altman analysis, we found wide limits of agreement. Moreover, the percentage error was 82% for NICOM w which is largely above the 30% cut-off that is commonly considered as acceptable when using a reference method with a precision of 15%, 13 as is the case with transpulmonary thermodilution. 10 A device measuring cardiac output must not only be able to provide reliable absolute values but also to detect changes. 14 In the present study, there was no significant correlation between the volume expansion-induced changes in CI Nicom and CI td . Finally, bioreactance was unable to assess the effects of the PLR test. While changes in CI during PLR allowed prediction of fluid responsiveness when CI was measured by pulse contour analysis, this was not the case at all when CI was estimated by the NICOM w device. Interestingly, the results were not better when excluded patients with cardiac arrhythmias and spontaneous breathing activity, suggesting that these limitations did not explain the poor reliability of the system. There was a trend towards that Volume-responders (n¼19) 94 (22) 93 (21) 94 (23) 93 (21) Non-volume-responders (n¼29) 90 (20) 89 (20) 91 (18) 89 (18) Mean arterial pressure [mean (SD), mm Hg]
Volume-responders (n¼19) 82 (16) 83 (14) 83 (13) 85 (13) Non-volume-responders (n¼29) 79 (11) 80 (11) 82 (12) 82 ( after PLR, the NICOM w CI values failed to return to baseline. One has to suspect that lung volume changed during the PLR in a way such that it did not totally return to baseline, which could alter the bioreactance estimation of cardiac output. Furthermore, volume loading had minimal effect on the CI Nicom . One could hypothesize that volume expansion would reduce haemoglobin levels and possibly alter the bioreactance reading, which is related to the iron content of the thorax. 15 So far, only a few studies have validated bioreactance technology. Comparing bioreactance with continuous pulmonary thermodilution in a large number of measurements after cardiac surgery, Squara and colleagues 3 found that the percentage error was 30%. In this study, changes in cardiac output were not induced by systematic therapeutic interventions. The same team confirmed these previous results when comparing NICOM w with transpulmonary thermodilution during lung recruitment manoeuvres. 5 Nevertheless, in this study, the percentage error of bioreactance was .30% (33%) on average. Marqué and colleagues 16 found a good agreement between NICOM w and Vigileo, but the latter technique can hardly be considered a gold standard for measuring cardiac output. 17 In contrast to these positive results, Fagnoul and colleagues 6 recently demonstrated that the NICOM w device was unreliable compared with pulmonary thermodilution for estimating cardiac output in a population similar to ours (coefficient of correlation: 0.13). NICOM w was also found unreliable when compared with echocardiography in newborns. 8 NICOM w was used for assessing the effects of PLR and it was found reliable in two studies, 9 18 19 but importantly NICOM w was not compared with a reference technique in those studies. Taken together, these results could suggest that the reliability of the device might be different depending on the context, the positive studies being conducted in the perioperative period and the negative studies being conducted in ICUs. Interestingly, in the same context of septic patients, bioimpedance was shown to be unreliable compared with pulmonary thermodilution. 20 In animals, Critchley and colleagues 21 showed that the reliability of bioimpedance was influenced by the level of peripheral resistance. This suggests that septic shock may be a specific context where bioimpedance and thus bioreactance could be less reliable than in others, which could explain the unreliability of the NICOM w device in our population with a large majority of septic shock patients. Also, in an animal model of acute respiratory distress syndrome, the team of Critchley suggested that the unreliability of bioimpedance could be due to changes in lung fluid. 22 They confirmed later that in critically ill patients, the degree of bioimpedance unreliability was related to the extent of lung injury and fluid accumulation within the thorax. 23 Even though we could not investigate this specific issue, it could explain the poor results we obtained with bioreactance in our population in which the incidence of acute respiratory distress syndrome was high. Our study has certain limitations. The first is that it included only ICU patients, most of whom were in septic shock. Thus, our results might not be able to be extrapolated to other contexts like the operating theatre, where artifacts limiting the bioreactance technique are less frequent. Also, we were unable to determine the reason why bioreactance performed so badly for estimating cardiac output, even though we suggest that this was not related to the presence of spontaneous breathing activity, cardiac arrhythmias, or both. Finally, we did not investigate another variable provided by the NICOM w device, the total fluid content. It was not the purpose of this study to validate this variable, which has recently demonstrated to diagnose acute decompensated heart failure in an emergency department. 24 
Conclusions
The bioreactance technique was unable to estimate absolute values or relative changes in CI in critical care patients. It was also unable to assess the effects of a PLR test to predict fluid responsiveness.
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